SPATA19 Antikörper (N-Term)
Kurzübersicht für SPATA19 Antikörper (N-Term) (ABIN1450102)
Target
Alle SPATA19 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- SPATA19 antibody was raised against an 17 amino acid synthetic peptide near the amino terminus of human SPATA19.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store the antibody (in aliquots) at -20 °C.
-
-
- SPATA19 (Spermatogenesis Associated 19 (SPATA19))
-
Andere Bezeichnung
- SPATA19 / SPERGEN1
-
Hintergrund
- SPATA19, also known as SPERGEN1, was initially identified as a testis-specific protein that localizes to the surface of mitochondria in the middle piece of mature spermatozoa. Recent experiments have shown that elevated levels of SPATA19 have been found in basal cell carcinomas and prostate cancers, suggesting that SPATA19 may serve as a putative cancer biomarker and a target for cancer immunotherapy.Synonyms: FLJ25851, SPAS1, Spergen-1, Spermatogenesis-associated protein 19, Spermatogenic cell-specific gene 1 protein
-
Gen-ID
- 219938
Target
-